Poor door
Poor door is a term used to describe a separate entrance in a multi-unit residential building, typically one that is used by residents of the affordable housing units, while the main entrance is reserved for residents of the market-rate or luxury units. This practice has been criticized for promoting social segregation and economic inequality.
Background[edit | edit source]
The concept of the poor door emerged in response to inclusionary zoning policies, which require developers to include a certain percentage of affordable housing units in new residential developments. To comply with these regulations while maintaining the exclusivity of their luxury units, some developers have created separate entrances for the affordable housing residents.
Criticism[edit | edit source]
The use of poor doors has been widely criticized by housing advocates, policymakers, and the general public. Critics argue that it reinforces social and economic divisions, stigmatizes low-income residents, and undermines the goals of inclusionary zoning policies. The practice has been described as a form of economic segregation and has sparked debates about housing policy and urban planning.
Regulation[edit | edit source]
In some cities, the backlash against poor doors has led to changes in housing regulations. For example, in 2015, New York City passed legislation to prevent the use of separate entrances for affordable housing units in new developments. Other cities have considered or implemented similar measures to ensure that all residents have equal access to building amenities and entrances.
Examples[edit | edit source]
Several high-profile developments have been noted for their use of poor doors. These cases have often attracted media attention and public outcry, leading to increased scrutiny of the practice and calls for regulatory reform.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Lua error in mw.title.lua at line 318: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal').
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD